Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner. Facebook Messenger An icon of the facebook messenger app logo. Facebook An icon of a facebook f logo. Facebook Messenger An icon of the Twitter app logo. LinkedIn An icon of the LinkedIn logo. WhatsApp Messenger An icon of the Whatsapp messenger app logo. Email An icon of an mail envelope. Copy link A decentered black square over a white square.

Blood test hope for prostate cancer patients

Prostate cancer awareness ribbon (Getty)
Prostate cancer awareness ribbon (Getty)

A BLOOD test for potentially lethal prostate cancer could be in sight after scientists linked circulating tumour cells and more dangerous forms of the disease.

Researchers in the UK studied 80 blood samples from men with prostate cancer. Those from men whose cancer had spread or was more aggressive were found to contain larger numbers of free tumour cells.

In future, testing for circulating prostate cancer cells could help doctors identify high risk patients who may need more radical treatment.

Lead scientist Dr Yong-Jie Lu, from Queen Mary, University of London’s Barts Cancer Institute, said: “Our research shows that the number of these specific cells in a patient’s sample is a good indicator of prostate cancer spreading.

“By identifying these cells, which have gained the ability to move through the body, we have found a potential new way to monitor the disease.

“If we’re able to replicate these studies in larger groups of people, we may be able to one day predict the risk of someone’s cancer spreading so they can make more informed treatment decisions.”

Each year in the UK around 46,500 men are diagnosed with prostate cancer and 11,000 die from the disease.

Prostate cancer can exist in the form of low-grade “pussycat” tumours that can simply be monitored or dangerous “tigers” which are likely to grow fast and spread.

Currently there is no simple way of telling what kind of cancer a patient has.

The new findings were presented at the National Cancer Research Institute (NCRI) cancer conference taking place in Liverpool.

Dr Chris Parker, chairman of the NCRI’s Prostate Cancer Clinical Studies Group, said: “There’s a need to develop better tests to identify and monitor men with aggressive prostate cancer. This research has found a promising new marker that could one day make it to the clinic to guide treatment decisions.”


READ MORE

Prostate cancer survival rates very high regardless of treatment, study finds

Sir Michael Parkinson urges men not to ignore risk of prostate cancer